Denali Therapeutics Inc. (DNLI) — Stock Score Summary

Denali Therapeutics Inc. (DNLI) has a MoatMap StockRank of 42/100 based on Quality (33/100), Value (36/100), and Momentum (60/100) factor scores. The current signal is HOLD. A clinical-stage biopharma company focused on neurodegenerative diseases with low quality metrics and no alignment with our CDMO or other macro themes.

Denali Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing therapies for neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS. Its competitive advantage lies in its proprietary scientific platforms, including its "Transport Vehicle" technology designed to enable drugs to cross the blood-brain barrier effectively. The company maintains a focused pipeline and strategic partnerships, positioning itself as a leader in addressing challenging neurological conditions.

Key Financial Metrics

Price$20.79
Market Cap$3.3B
P/E (Forward)-8.19
Price/Book3.45
Return on Equity-49.6%
Return on Invested Capital-53.1%
Debt/Equity4.32
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-190M

Denali Therapeutics Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Denali Therapeutics Inc.’s (DNLI) StockRank?
MoatMap’s StockRank for Denali Therapeutics Inc. (DNLI) is 42/100, with a Hold signal. It is a composite of Quality (33), Value (36), and Momentum (60) factor ranks across MoatMap’s 19,000+ stock universe.
Does Denali Therapeutics Inc. have an economic moat?
Denali Therapeutics Inc. (DNLI) has a Quality factor score of 33/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Denali Therapeutics Inc. a buy, hold, or sell?
MoatMap’s current signal for Denali Therapeutics Inc. (DNLI) is Hold, based on a StockRank of 42/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Denali Therapeutics Inc. in?
Denali Therapeutics Inc. (DNLI) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksDNLI deep dive reportAI ChampionsHow we score stocksSense-check another stock